Naslov
Mortality and incidence of malignant arrhythmias in patients with dilated cardiomyopathy and implantable cardioverter defibrillator in primary and secondary prevention

Autori
Stipinović, Mario ; Počanić, Darko ; Marković, Matija ; Andreykanich, Sofiya ; Letilović, Tomislav ; Premužić Meštrović, Ivica ; Kurtić, Ena ; Aćamović Stipinović, Bojana ; Jerkić, Helena

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, prošireni sažetak, ostalo

Izvornik
Cardiologia Croatica 2018 ; 13(11-12):342 / - , 2018, 342-342

Skup
12. kongres Hrvatskoga kardiološkog društva ; 7. kongres Hrvatske udruge kardioloških medicinskih sestara = 12th Congress of the Croatian Cardiac Society ; 7th Congress of the Croatian Association of Cardiology Nurses

Mjesto i datum
Zagreb, Hrvatska, 29.11.2018. - 02.12.2018

Vrsta sudjelovanja
Ostalo

Vrsta recenzije
Domaća recenzija

Ključne riječi
dilatativna kardiomiopatija, implantabilni kardioverter defibrilator, iznenadna srčana smrt
(dilated cardiomyopathy, implantable cardioverter defibrillator, sudden cardiac death.)

Sažetak
Introduction: Implantation of implantable cardioverter defibrillator (ICD) as a primary prevention (PP) is indicated in patients with dilated cardiomyopathy (DCM) with a reduced ejection fraction as well as a life expectancy longer than a year. Implantation of ICD as a secondary prevention (SP) is indicated after cardiac arrest and in patients with symptomatic ventricular tachycardia. Results of a Danish register did not show mortality to decrease in patients with non-ischaemic cardiomyopathy (NCM).1, 2 The goal of our research is to analyze results from University Hospital “Merkur”. Results and Conclusion: From 2012 up to 2017 a total of 89 ICDs were implanted due to DCM, 69 for PP and 20 for SP. Data was collected retrospectively and analyzed. The average age of our patients was 62.9 years, 13 out of 89 were women. The average follow up lasted 32 months. 69 patients were treated due to PP, 36 with ischemic cardiomyopathy (ICM) vs 33 with NCM. Death occurred in 9 patients (7 with ICM vs 2 with NCM), 7 died due to heart failure (HF) and 2 due to noncardiovascular cause (in NCM group). Sudden cardiac death (SCD) was prevented in 12 patients (7 ICM vs 5 NCM). There were 30 appropriate ICD therapy deliveries, significantly more in the group of patients with ICM (23 vs 7 ; p < 0.05). In patients younger then 59 (29 patients) ICD therapy was delivered in 3 patients, and in a group of older patients (40 patients) ICD therapy was delivered in 9 patients. 15 patients with ICM and 5 with NCM were treated due to SP. Death occurred in 5 patients (3 ICM vs 2 NCM), all due to HF. In 4 patients SCD was prevented (3 ICM vs 1 NCM). There were 8 appropriate ICD therapy deliveries (7 ICM vs 1 NCM). 16 patients were older then 59, and all patients in which SCD was prevented, were older then 59. In both groups there were 51 patient with ICM and 38 with NCM. Death occurred in 14 patients (5 ICM and 9 NCM). SCD was prevented in 16 patients (10 ICM vs 6 NCM). In total there were 38 appropriate ICD therapy deliveries (30 ICM and 8 NCM, p<0.05) and all of them occurred in men (p<0.05). There were 33 patients younger then 59 (with 3 appropriate ICD discharge) and 56 older than 59 (with 14 appropriate ICD discharge). We did not detect a significant difference in total mortality between ICM and NCM, neither in the number of SCD. Statistically significant higher numbers of appropriate ICD discharge was detected in the ICM group for PP and in total. Male gender carries a higher risk for SCD. Younger age does not carry a higher risk for SCD.

Izvorni jezik
Hrvatski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA